CD274 and neoplasm: PD-L1 was expressed in 7.1% of CD3+ T cells overall; and by 3.8% (range 0.0–64.9%) and 7.5% (range 0.3–44.7%) of CD3+ T cells in tumour and stromal compartments respectively.